Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease
Chih‐Wei Tung, Pin-Yu Huang, Siew Chin Chan, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases
Delsuz Rezaee, Fatemeh Saadatpour, Nayyereh Akbari, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102090-102090
Closed Access | Times Cited: 44
Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies
Huichun Tong, Tianqi Yang, Shuying Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3845-3845
Open Access | Times Cited: 21
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Sarika V. Kapplingattu, Sujata Bhattacharya, Yogita K. Adlakha
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases
Raya Kh. Yashooa, Elisa Duranti, Donatella Conconi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 626-626
Open Access | Times Cited: 2
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 36
Improved surface-enhanced Raman scattering detection of miRNA employing polyhedral gold plasmonic nanoparticles in conjunction with DNA cascade amplification strategy
Yufei Zang, Xu Yang, Lin Zhao, et al.
Sensors and Actuators B Chemical (2025), pp. 137320-137320
Closed Access | Times Cited: 1
Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases
Neeraj Mishra, Sumel Ashique, Ashish Garg, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1431-1440
Closed Access | Times Cited: 30
Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism
Seo-Young Koo, Eun‐Ji Park, Hyun-Ji Noh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8441-8441
Open Access | Times Cited: 20
Therapeutic advances in neural regeneration for Huntington's disease
Francesco D’Egidio, Vanessa Castelli, Giorgia Lombardozzi, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1991-1997
Open Access | Times Cited: 16
Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies
Ajmal Nassar, Sairaj Satarker, Prasada Chowdari Gurram, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5557-5577
Open Access | Times Cited: 14
A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders
Sara Abdolahi, Ameneh Zare-Chahoki, Farshid Noorbakhsh, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6260-6280
Open Access | Times Cited: 21
The updated development of blood-based biomarkers for Huntington’s disease
Sirui Zhang, Yangfan Cheng, Huifang Shang
Journal of Neurology (2023) Vol. 270, Iss. 5, pp. 2483-2503
Open Access | Times Cited: 11
The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease
Reda Mansour, A. A. Shaker, Ahmed I. Abulsoud, et al.
Molecular Neurobiology (2025)
Closed Access
Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights
Chih‐Wei Tung, Siew Chin Chan, Pei‐Hsun Cheng, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Unlocking Parkinson’s disease: the role of microRNAs in regulation, diagnosis, and therapy
Xiaodong Li, Qiang Fu, Mei Guo, et al.
APOPTOSIS (2025)
Closed Access
RNA-based therapies for neurodegenerative disease: Targeting molecular mechanisms for disease modification
Vishal Bhati, Sonima Prasad, Atul Kabra
Molecular and Cellular Neuroscience (2025), pp. 104010-104010
Closed Access
Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington’s Disease Brain
Séréna Petry, Behnaz Nateghi, Rémi Keraudren, et al.
Neuroscience (2022) Vol. 518, pp. 54-63
Closed Access | Times Cited: 15
miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease
Siew Chin Chan, Chih‐Wei Tung, Chia-Wei Lin, et al.
Free Radical Biology and Medicine (2023) Vol. 209, pp. 292-300
Closed Access | Times Cited: 9
Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis
Renqing Zhao
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Emerging Role of MicroRNA-30c in Neurological Disorders
Manish Kumar, Guohong Li
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 37-37
Open Access | Times Cited: 12
Plasma microRNA-221-3p as a biomarker for POCD after non-cardiac surgery
Di Fan, Xuhui Chen, Hongli Zhou, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0275917-e0275917
Open Access | Times Cited: 9
Differential microRNA expression in the SH-SY5Y human cell model as potential biomarkers for Huntington’s disease
Ayaz M. Belkozhayev, Raigul Niyazova, Mohammad Amjad Kamal, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington’s disease
Behnaz Nateghi, Rémi Keraudren, Gabriel Boulay, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Intranuclear inclusions of polyQ-expanded ATXN1 sequester RNA molecules
Ioannis Gkekas, Aimilia-Christina Vagiona, Nikolaos Pechlivanis, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 3
Non-coding RNAs as key players in the neurodegenerative diseases: Multi-platform strategies and approaches for exploring the Genome’s dark matter
Hailah M. Almohaimeed, Rasha Assiri, Eman Hillal Althubaiti, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 129, pp. 102236-102236
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top